DHAI Stock Overview
Operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
DIH Holding US, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.00 |
| 52 Week High | US$13.90 |
| 52 Week Low | US$0.72 |
| Beta | -0.65 |
| 11 Month Change | -41.18% |
| 3 Month Change | -60.63% |
| 1 Year Change | -90.88% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -89.85% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of DIH Holding US, Inc. (NASDAQ:DHAI)
Nov 15
DIH Holding Offers Promising Healthcare Technologies, But Remains A Speculative Stock
Jun 24Investors Still Aren't Entirely Convinced By DIH Holding US, Inc.'s (NASDAQ:DHAI) Revenues Despite 76% Price Jump
Jun 18A Piece Of The Puzzle Missing From DIH Holding US, Inc.'s (NASDAQ:DHAI) 38% Share Price Climb
May 04Shareholder Returns
| DHAI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -21.3% | -1.2% | -2.1% |
| 1Y | -90.9% | 22.4% | 29.6% |
Return vs Industry: DHAI underperformed the US Medical Equipment industry which returned 22.4% over the past year.
Return vs Market: DHAI underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| DHAI volatility | |
|---|---|
| DHAI Average Weekly Movement | 14.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DHAI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: DHAI's weekly volatility has decreased from 21% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Jason Chen | www.dih.com |
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research.
DIH Holding US, Inc. Fundamentals Summary
| DHAI fundamental statistics | |
|---|---|
| Market cap | US$40.54m |
| Earnings (TTM) | -US$3.33m |
| Revenue (TTM) | US$72.41m |
0.6x
P/S Ratio-12.2x
P/E RatioIs DHAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHAI income statement (TTM) | |
|---|---|
| Revenue | US$72.41m |
| Cost of Revenue | US$35.32m |
| Gross Profit | US$37.09m |
| Other Expenses | US$40.42m |
| Earnings | -US$3.33m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.082 |
| Gross Margin | 51.22% |
| Net Profit Margin | -4.60% |
| Debt/Equity Ratio | -35.8% |
How did DHAI perform over the long term?
See historical performance and comparison